The goal of this work was to determine whether deletion of ghrelin might prevent the age‐associated NAFLD and to determine whether its effects are mediated through the p300‐C/EBPα/β pathway. Here, GHRL is linked to metabolic dysfunction-associated steatotic liver disease.